Skip to main content
logo
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
6.44
-0.05 (-0.77%)
Aug 12, 2025, 10:47 AM EDT

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 107.36M CAD in the quarter ending June 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to 384.56M, up 13.82% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
384.56M
Revenue Growth
+13.82%
P/S Ratio
1.68
Revenue / Employee
516.19K
Employees
745
Market Cap
646.75M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Green Thumb Industries1.57B
Curaleaf Holdings1.75B
Sienna Senior Living896.45M
dentalcorp Holdings1.62B
Trulieve Cannabis1.62B
WELL Health Technologies990.34M
Cronos Group177.69M
Extendicare1.51B
Revenue Rankings

Knight Therapeutics News

More News